Robert Bain Thomas, Director at REVA Medical, Inc. (RVA), bought 10,000 shares at $4.03 ($42K) on 2013-12-06, disclosed to the SEC on 2013-12-10.
Open-market purchase of $42k RVA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.03 | 7,500 | $30K | 72.4% |
| 2 | $4.60 | 2,500 | $12K | 27.6% |
| Total | $4.17 avg | 10,000 | $42K | 100% |
| Filing → |
| RVA.AX | BUY | 2018-06-01 | $10K | — | Filing → |
| RVA.AX | BUY | 2018-03-30 | $15K | — | Filing → |
| RVA.AX | BUY | 2018-03-28 | $15K | — | Filing → |